Peroxisome proliferator–activated receptor- γ agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty
- Resource Type
- Article
- Source
- In
Metabolism 2005 54(5):590-597 - Subject
- Language
- ISSN
- 0026-0495